SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,354.04 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 505.36 |
| Book Value / Share | 6.94 |
| Price / Book | n/a |
| NCAV ($M) | -215.60 |
| NCAV / Share | -2.96 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.09 |
| Return on Assets (ROA) | 0.08 |
| Return on Equity (ROE) | 0.17 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.16 |
| Current Ratio | 1.86 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 362.56 |
| Assets | 1,083.52 |
| Liabilities | 578.16 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 871.96 |
| Operating Income | 130.70 |
| Net Income | 80.55 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 109.89 |
| Cash from Investing | -69.74 |
| Cash from Financing | -54.01 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| ARDS – Aridis Pharmaceuticals, Inc. | ARGNF – argenx SE |
| ARNI – Arno Therapeutics, Inc. | ATHXQ – Athersys, Inc. |
| ATRX – Adhera Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io